Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
13.36
+0.19 (1.44%)
At close: Dec 20, 2024, 4:00 PM
13.45
+0.09 (0.67%)
After-hours: Dec 20, 2024, 4:07 PM EST

Myriad Genetics Market Cap

Myriad Genetics has a market cap or net worth of $1.22 billion as of December 20, 2024. Its market cap has decreased by -19.58% in one year.

Market Cap
1.22B
Enterprise Value
1.26B
1-Year Change
-19.58%
Ranking
Category
Stock Price
$13.36

Market Cap Chart

Since December 1, 1998, Myriad Genetics's market cap has increased from $102.30M to $1.22B, an increase of 1,088.89%. That is a compound annual growth rate of 9.96%.

History

DateMarket Cap% Change
Dec 20, 20241.22B-22.70%
Dec 29, 20231.57B33.81%
Dec 30, 20221.18B-46.65%
Dec 31, 20212.20B48.19%
Dec 31, 20201.49B-26.57%
Dec 31, 20192.03B-6.80%
Dec 31, 20182.17B-8.61%
Dec 29, 20172.38B108.51%
Dec 30, 20161.14B-62.13%
Dec 31, 20153.01B21.14%
Dec 31, 20142.49B58.51%
Dec 31, 20131.57B-29.30%
Dec 31, 20122.22B25.03%
Dec 30, 20111.77B-15.91%
Dec 31, 20102.11B-15.93%
Dec 31, 20092.51B-18.54%
Dec 31, 20083.08B50.95%
Dec 31, 20072.04B64.00%
Dec 29, 20061.24B93.29%
Dec 30, 2005643.90M-6.71%
Dec 31, 2004690.20M98.11%
Dec 31, 2003348.40M-0.17%
Dec 31, 2002349.00M-71.84%
Dec 31, 20011.24B-34.15%
Dec 29, 20001.88B304.51%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Arvinas 1.27B
Intellia Therapeutics 1.24B
STAAR Surgical Company 1.22B
Progyny 1.22B
Harrow 1.22B
Artivion 1.19B
Pediatrix Medical Group 1.19B
Embecta 1.18B
Market Cap Rankings